Efficacy and safety of endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors (TKI) after programmed cell death 1 (PD-1) inhibitor treatment in patients with metastatic clear cell renal cell carcinoma (mccRCC).

Programmed Cell Death 1 ◽

Inhibitor Treatment

Safety and clinical activity of vascular endothelial growth factor receptor (VEGFR)–tyrosine kinase inhibitors after programmed cell death 1 inhibitor treatment in patients with metastatic clear cell renal cell carcinoma

Annals of Oncology ◽

10.1093/annonc/mdw160 ◽

2016 ◽

Vol 27 (7) ◽

pp. 1304-1311 ◽

Cited By ~ 34

Author(s):

R. Nadal ◽

A. Amin ◽

D.M. Geynisman ◽

M.H. Voss ◽

M. Weinstock ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Kinase Inhibitors ◽

Clear Cell ◽

Growth Factor Receptor ◽

Clinical Activity ◽

Vascular Endothelial ◽

Programmed Cell Death 1 ◽

Inhibitor Treatment

Sarcomatoid Dedifferentiation in Metastatic Clear Cell Renal Cell Carcinoma and Outcome on Treatment With Anti–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: A Retrospective Analysis

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2014.04.004 ◽

2014 ◽

Vol 12 (5) ◽

pp. e205-e214 ◽

Cited By ~ 26

Author(s):

Benoit Beuselinck ◽

Evelyne Lerut ◽

Pascal Wolter ◽

Herlinde Dumez ◽

Johannes Berkers ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Kinase Inhibitors ◽

Clear Cell ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

MP72-06 CORRELATION OF THE INSULIN RECEPTOR EXPRESSION AND THE RESISTANCE TO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA

The Journal of Urology ◽

10.1016/j.juro.2018.02.2290 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Masayuki Takahashi ◽

Kei Daizumoto ◽

Yayoi Fukuhara ◽

Keisuke Ozaki ◽

Megumi Tsuda ◽

...

Keyword(s):

Kinase Inhibitors ◽

Clear Cell ◽

Growth Factor Receptor ◽

Receptor Expression ◽

Vascular Endothelial ◽

Insulin Receptor Expression ◽

Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor–targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data

European Urology Oncology ◽

10.1016/j.euo.2019.12.004 ◽

2020 ◽

Vol 3 (2) ◽

pp. 168-173 ◽

Cited By ~ 3

Author(s):

Roderick de Bruijn ◽

Akhila Wimalasingham ◽

Bernadett Szabados ◽

Grant D. Stewart ◽

Sarah J. Welsh ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Clear Cell ◽

Prospective Trial ◽

Growth Factor Receptor ◽

Pooled Analysis ◽

Trial Data ◽

Vascular Endothelial ◽

Cytoreductive Nephrectomy ◽

Endothelial Growth Factor

Factors Modifying the Associations of Single or Combination Programmed Cell Death 1 and Programmed Cell Death Ligand 1 Inhibitor Therapies With Survival Outcomes in Patients With Metastatic Clear Cell Renal Cell Carcinoma

JAMA Network Open ◽

10.1001/jamanetworkopen.2020.34201 ◽

2021 ◽

Vol 4 (1) ◽

pp. e2034201

Author(s):

Neha Sati ◽

Devon J. Boyne ◽

Winson Y. Cheung ◽

Sarah B. Cash ◽

Paul Arora

Keyword(s):

Renal Cell Carcinoma ◽

Cell Death ◽

Programmed Cell Death ◽

Cell Carcinoma ◽

Renal Cell ◽

Clear Cell ◽

Survival Outcomes ◽

Programmed Cell Death 1

1337: Endothelial Expression of Vascular Endothelial Growth Factor Receptor 3 (VEGFR-3), but not VEGFR-1 or VEGFR-2, Predicts Survival in Clear Cell Renal Cell Carcinoma (RCC)

The Journal of Urology ◽

10.1016/s0022-5347(18)35482-x ◽

2005 ◽

Vol 173 (4S) ◽

pp. 363-364

Author(s):

John T. Leppen ◽

John S. Lam ◽

Hong Yu ◽

David B. Seligson ◽

Jun Dong ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Cell Carcinoma ◽

Renal Cell ◽

Clear Cell ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Elevated microRNA-185 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in clear cell renal cell carcinoma

Tumor Biology ◽

10.1007/s13277-014-2602-9 ◽

2014 ◽

Vol 35 (12) ◽

pp. 12757-12763 ◽

Cited By ~ 7

Author(s):

Hai-Xia Yuan ◽

Jian-Ping Zhang ◽

Wen-Tao Kong ◽

Yu-Jun Liu ◽

Zong-Ming Lin ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Microvessel Density ◽

Renal Cell ◽

Clear Cell ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Comparison of Radiological Tumor Response Based on iRECIST and RECIST 1.1 in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Programmed Cell Death-1 Inhibitor Therapy

Korean Journal of Radiology ◽

10.3348/kjr.2020.0404 ◽

2020 ◽

Vol 21 ◽

Author(s):

Bingjie Zheng ◽

Ji Hoon Shin ◽

Hailiang Li ◽

Yanqiong Chen ◽

Yuan Guo ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Death ◽

Programmed Cell Death ◽

Cell Carcinoma ◽

Renal Cell ◽

Tumor Response ◽

Clear Cell ◽

Recist 1.1 ◽

Programmed Cell Death 1

Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-012-1148-8 ◽

2012 ◽

Vol 138 (4) ◽

pp. 687-693 ◽

Cited By ~ 15

Author(s):

Jae-Lyun Lee ◽

Inkeun Park ◽

Kwonoh Park ◽

Seongjoon Park ◽

Yongcheol Ahn ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Efficacy And Safety ◽

Outcomes of unselected patients with metastatic clear-cell renal cell carcinoma treated with first-line pazopanib therapy followed by vascular endothelial growth factor receptor tyrosine kinase inhibitors or mammalian target of rapamycin inhibitors: a sin

BJU International ◽

10.1111/bju.13374 ◽

2015 ◽

Vol 118 (2) ◽

pp. 264-271 ◽

Cited By ~ 10

Author(s):

Marc R. Matrana ◽

Tharakeswara Bathala ◽

Matthew T. Campbell ◽

Cihan Duran ◽

Aditya Shetty ◽

...

Keyword(s):

Kinase Inhibitors ◽

Clear Cell ◽

Mammalian Target Of Rapamycin ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

First Line ◽